Biosimilars: A Global Perspective of a New Market - Opportunities, Threats and Critical Strategies 2014: Single User

1888246 Preview

Report / Survey by Thomson Reuters BioWorld , 09/30/2014

Track This

Full Description

  • Interactive PDF of data, projections, and analysis
  • >100 deals involving follow-on biologics (FOBs) identified
  • 700 biosimilars and 245 companies profiled
  • Updates on approvals and pipeline developments
  • Analysis of competitive landscape, defensive strategies, and market share
  • Market/regulatory analysis of 25 countries in Europe, Asia/Pacific, Latin America, Middle East, Africa, and North America
  • Core drivers and IP issues impacting biosimilar growth
  • and much more

Enterprise version also available. See more

Also Bought By Customers

Order Options

Delivery Options
Price: $3,995.00
Available for Immediate Download

Product Details

Edition:

Mari Serebrov

Published:

09/30/2014

Number of Pages:

268

File Size:

1 file